Skip to main content
Top
Published in: Annals of Surgical Oncology 3/2017

01-12-2017 | Breast Oncology

Comment on: Sentinel Node Biopsy Using Magnetic Tracer Versus Standard Technique: The SentiMAG Multicentre Trial

Authors: Emmanuel Barranger, MD, PhD, Tarik Ihrai, MD

Published in: Annals of Surgical Oncology | Special Issue 3/2017

Login to get access

Excerpt

The standard practice in breast cancer surgery is to mandate a sentinel node biopsy (SNB) for all patients without clinically negative axillary lymph node. To date, the “gold standard” for detecting the sentinel lymph node (SLN) is a combination of blue dye and radioisotope.1 However, in recent years, the use of these tracers has been controversial because of allergic complications involving blue dye and organizational difficulties regarding the radioisotopic method. This has led some teams to develop new tracers for SLN localization. Thus, a magnetic tracer was recently developed to replace potentially one of two commonly used tracers. …
Literature
1.
go back to reference Kim T, Giuliano AE, Lyman GH. Lymphatic mapping and sentinel lymph node biopsy in early-stage breast carcinoma. Cancer. 2006;106:4–16.CrossRefPubMed Kim T, Giuliano AE, Lyman GH. Lymphatic mapping and sentinel lymph node biopsy in early-stage breast carcinoma. Cancer. 2006;106:4–16.CrossRefPubMed
2.
go back to reference Douek M, Klaase J, Monypenny I, Kothari A, Zechmeister K, Brown D, et al; On behalf of the SentiMAG Trialists Group. Sentinel node biopsy using a magnetic tracer versus standard technique: the SentiMAG Multicentre Trial. Ann Surg Oncol. 2013;21(4):1237–45.CrossRefPubMed Douek M, Klaase J, Monypenny I, Kothari A, Zechmeister K, Brown D, et al; On behalf of the SentiMAG Trialists Group. Sentinel node biopsy using a magnetic tracer versus standard technique: the SentiMAG Multicentre Trial. Ann Surg Oncol. 2013;21(4):1237–45.CrossRefPubMed
Metadata
Title
Comment on: Sentinel Node Biopsy Using Magnetic Tracer Versus Standard Technique: The SentiMAG Multicentre Trial
Authors
Emmanuel Barranger, MD, PhD
Tarik Ihrai, MD
Publication date
01-12-2017
Publisher
Springer International Publishing
Published in
Annals of Surgical Oncology / Issue Special Issue 3/2017
Print ISSN: 1068-9265
Electronic ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-017-6191-x

Other articles of this Special Issue 3/2017

Annals of Surgical Oncology 3/2017 Go to the issue

Urologic Oncology

Age and Charlson Score